Table 4.
Subgroup analysis of TyG index and mortality in patients with T2D.
| Cutoff value | N | All-cause mortality | P for log likelihood ratio test | CVD mortality | P for log likelihood ratio test | ||
|---|---|---|---|---|---|---|---|
| HR (95% CI), p value | HR (95% CI), p value | ||||||
| < 8.95 | ≥ 8.95 | < 9.00 | ≥ 9.00 | ||||
| Age, years | |||||||
| ≥ 65 | 1444 | 0.75 (0.51, 1.10), 0.135 | 1.28 (1.03, 1.60), 0.027 | 0.007 | 0.85 (0.44, 1.63), 0.621 | 1.49 (1.00, 2.22), 0.050 | 0.065 |
| < 65 | 1554 | 0.90 (0.46, 1.75), 0.750 | 1.15 (0.92, 1.44), 0.215 | 0.369 | 0.48 (0.14, 1.63), 0.238 | 1.18 (0.76, 1.81), 0.458 | 0.144 |
| Gender | |||||||
| Male | 1594 | 0.87 (0.57, 1.34), 0.535 | 1.18 (0.96, 1.46), 0.116 | 0.047 | 0.78 (0.35, 1.70), 0.526 | 1.64 (1.14, 2.35), 0.007 | 0.021 |
| Female | 1404 | 0.59 (0.34, 1.01), 0.056 | 1.34 (1.05, 1.71), 0.017 | 0.018 | 0.69 (0.26, 1.83), 0.457 | 1.19 (0.72, 1.98), 0.498 | 0.249 |
| HbA1c, % | |||||||
| < 6.5 | 1115 | 0.92 (0.58, 1.46).0.723 | 1.18 (0.74, 1.87), 0.495 | 0.401 | 1.15 (0.49, 2.70), 0.740 | 1.21 (0.47, 3.12), 0.698 | 0.768 |
| ≥ 6.5 | 1883 | 0.65 (0.40, 1.06), 0.085 | 1.28 (1.08, 1.52), 0.004 | 0.009 | 0.59 (0.26, 1.32), 0.200 | 1.44 (1.06, 1.97), 0.022 | 0.026 |
| BMI, kg/m2 | |||||||
| < 25 | 530 | 0.63 (0.33, 1.20), 0.158 | 1.40 (0.95, 2.04), 0.086 | 0.014 | 0.47 (0.10, 2.22), 0.341 | 1.74 (0.79, 3.83), 0.170 | 0.209 |
| ≥ 25 | 2468 | 0.88 (0.59, 1.32), 0.542 | 1.32 (1.11, 1.57), 0.002 | 0.077 | 0.76 (0.40, 1.43), 0.390 | 1.50 (1.09, 2.06), 0.013 | 0.042 |
| Smoking status | |||||||
| Yes | 1549 | 0.87 (0.56, 1.36), 0.551 | 1.29 (1.06, 1.57), 0.010 | 0.021 | 0.74 (0.35, 1.59), 0.439 | 1.77 (1.23, 2.54), 0.002 | 0.012 |
| No | 1449 | 0.57 (0.34, 0.96), 0.033 | 1.26 (0.97, 1.63), 0.080 | 0.014 | 0.67 (0.27, 1.66), 0.388 | 1.25 (0.78, 2.02), 0.355 | 0.178 |
All subgroups were adjusted for age, sex, education level, race/ethnicity, PIR, smoking status, drinking status, BMI, CHD, HF, heart attack, stroke, angina, hypertension, hyperlipidemia, glucose-lowering medication use, HbA1c, LDL-C, and TC. We excluded stratification variables from the model in the analysis of single subgroups.